Seattle Genetics and Merck Announce Two Strategic Oncology Collaborations
Go back to Seattle Genetics and Merck Announce Two Strategic Oncology Collaborations| Merck & Co. (NYSE: MRK) | Delayed: 129.56 +4.19 (3.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $125.37 | 52 Week High | $65.46 | |||
| Open | $126.18 | 52 Week Low | $47.97 | |||
| Day High | $129.61 | P/E | 88.14 | |||
| Day Low | $125.99 | EPS | $1.47 | |||
| Volume | 7,833,992 | |||||
| Seattle Genetics Inc /wa (NASDAQ: SGEN) | Delayed: 228.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $228.74 | 52 Week High | $75.36 | |||
| Open | $22.94 | 52 Week Low | $26.02 | |||
| Day High | $228.74 | P/E | N/A | |||
| Day Low | $228.74 | EPS | $-0.51 | |||
| Volume | 759,302 | |||||
